Advancing In Silico Clinical Trials for Regulatory Adoption and Innovation
- PMID: 39514353
- DOI: 10.1109/JBHI.2024.3486538
Advancing In Silico Clinical Trials for Regulatory Adoption and Innovation
Abstract
The evolution of information and communication technologies has affected all fields of science, including health sciences. However, the rate of technological innovation adoption by the healthcare sector has been historically slow, compared to other industrial sectors. Innovation in computer modeling and simulation approaches has changed the landscape in biomedical applications and biomedicine, paving the way for their potential contribution in reducing, refining, and partially replacing animal and human clinical trials. In Silico Clinical Trials (ISCT) allow the development of virtual populations used in the safety and efficacy testing of new drugs and medical devices. This White Paper presents the current framework for ISCT, the role of in silico medicine research communities, the different perspectives (research, scientific, clinical, regulatory, standardization, data quality, legal and ethical), the barriers, challenges, and opportunities for ISCT adoption. In addition, an overview of successful ISCT projects, market-available platforms, and FDA- approved paradigms, along with their vision, mission and outcomes are presented.
Similar articles
-
In silico clinical trials: concepts and early adoptions.Brief Bioinform. 2019 Sep 27;20(5):1699-1708. doi: 10.1093/bib/bby043. Brief Bioinform. 2019. PMID: 29868882 Review.
-
A risk and credibility framework for in silico clinical trials of medical devices.Comput Methods Programs Biomed. 2023 Dec;242:107813. doi: 10.1016/j.cmpb.2023.107813. Epub 2023 Sep 14. Comput Methods Programs Biomed. 2023. PMID: 37734216
-
Toward trustworthy medical device in silico clinical trials: a hierarchical framework for establishing credibility and strategies for overcoming key challenges.Front Med (Lausanne). 2024 Aug 12;11:1433372. doi: 10.3389/fmed.2024.1433372. eCollection 2024. Front Med (Lausanne). 2024. PMID: 39188879 Free PMC article.
-
Identifying the patient harms to include in an in silico clinical trial.Comput Methods Programs Biomed. 2023 Nov;241:107735. doi: 10.1016/j.cmpb.2023.107735. Epub 2023 Jul 30. Comput Methods Programs Biomed. 2023. PMID: 37544163
-
Credibility assessment of in silico clinical trials for medical devices.PLoS Comput Biol. 2024 Aug 8;20(8):e1012289. doi: 10.1371/journal.pcbi.1012289. eCollection 2024 Aug. PLoS Comput Biol. 2024. PMID: 39116026 Free PMC article. Review.
LinkOut - more resources
Full Text Sources
